Personal Genome Diagnostics (PGDx) is Empowering the Fight Against Cancer by unlocking actionable information from the genome. We are developing an innovative portfolio of regulated tissue-based and non-invasive liquid biopsy genomic products for laboratories worldwide.
Advancing NGS in Oncology
Advancing NGS in Oncology
PGDx began as a CAP/CLIA lab to provide clinical testing services for patients and research services for Pharma and academic partners. Our expertise in cancer genome analysis ranges from sample preparation and sequencing to data analysis and interpretation. We specialize in high-throughput next-generation sequencing and use proprietary algorithms to accurately identify alterations in complex cancer genomes.
PGDx is translating our genomic expertise and technologies into tissue-based and liquid biopsy products that can be distributed to and run in molecular laboratories worldwide, bringing testing back within the patient care ecosystem. We are committed to standardizing NGS oncology solutions for laboratories, giving access to patients worldwide.
PGDx is a team of talented individuals with a variety of backgrounds that are dedicated to advancing precision medicine in oncology through genomic technologies.join our team
Principal Scientist, Bioinformatics
“Our mission is my greatest motivation. I truly value the opportunity we have at PGDx to improve the lives of present and future cancer patients. This is not, and should not be, an easy task – nor should it be taken lightly.
Associate Scientist, Bioinformatics
“The work we’re doing at PGDx is enabling better research, better diagnostics, and better therapy for cancer patients. I can think of nothing more worthy to spend time and money on.”
“PGDx is changing the face of personalized medicine and trying to better patient outcomes around the globe. I hope that one day I can walk away from PGDx knowing that, even if in the smallest capacity, I was able to contribute to that achievement.”
Validation Manager, Lab Operations
“Whether providing real-time therapy - guiding results to current patients or through collaborations in biomarker discovery and diagnostic design, our efforts will ultimately shape outcomes for future cancer patients worldwide. What an incredibly honorable opportunity to be a part of!”
Strategic Alliance Manager
“Every day, it feels good to know that we work towards increasing access to precision medicine at the local level for patients across countries, cities, and neighborhoods.”
Bioinformatics Software Engineer
“I hope to leave things better than I found them, and enjoy the process. Cancer is a genetic disease, so making genetic testing more accessible, affordable, and accurate seems like a great place to start.”